vRRP1 cell line

Cat. #161789

vRRP1 cell line

Cat. #: 161789

Organism: Human

Tissue: Skin


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Inventor: Christoper Stipp

Institute: University Of Iowa Research Foundation

Primary Citation: Zhu et al. 2022. npj Precis. Onc. PMID: 36271142

Tool Details

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: vRRP1 cell line
  • Alternate name: vRRP1
  • Cancer: Skin cancer
  • Research fields: Cancer;Drug development
  • Parental cell: A375 Melanoma (ATCC)
  • Organism: Human
  • Gender: Female
  • Tissue: Skin
  • Donor: A375 (ATCC) -human melanoma cell line of a solid tumor from a 54-year-old female.
  • Morphology: Diffuse Morphology
  • Description: Drug-resistant sub-lines of A375 that are BRAF^V600E and NRAS WT. VRPP1 does not harbour NRAS mutations or BRAF genomic alterations, which drive drug resistance through MAPK-reactivation . It Is a VEM-resistant derivatives of A375. VRPP1 is RAC1 WT. Shows Increased VAV1 protein levels. Increased MEK Phosphorylation on S298 (Pak Site).
  • Production details: Spontaneous vemurafenib-resistant clones and populations were created after 2–3 and 4–6 weeks cultured in 3 mm vemurafenib. maintained in media with 3 mm vemurafenib.


  • Growth medium: DMEM(Gibco) suplemented with penicillin/streptomycin (Gibco) and 10% FBS (Gibco).


  • Feddersen et al.2019. Cancer Res. 79(19).PMID: 31416844